The estimated Net Worth of Robert J Terifay is at least $28.8 Milion dollars as of 10 August 2017. Robert Terifay owns over 1,921 units of Regeneron Pharmaceuticals stock worth over $28,780,520 and over the last 18 years Robert sold REGN stock worth over $0.
Robert has made over 18 trades of the Regeneron Pharmaceuticals stock since 2011, according to the Form 4 filled with the SEC. Most recently Robert exercised 1,921 units of REGN stock worth $99,950 on 10 August 2017.
The largest trade Robert's ever made was exercising 50,875 units of Regeneron Pharmaceuticals stock on 27 July 2012 worth over $918,803. On average, Robert trades about 14,647 units every 79 days since 2007. As of 10 August 2017 Robert still owns at least 25,214 units of Regeneron Pharmaceuticals stock.
You can see the complete history of Robert Terifay stock trades at the bottom of the page.
Over the last 22 years, insiders at Regeneron Pharmaceuticals have traded over $13,084,686,326 worth of Regeneron Pharmaceuticals stock and bought 8,562,481 units worth $2,539,854,760 . The most active insiders traders include Sanofi, Pharma Ag Novartis a Leonard S Schleifer. On average, Regeneron Pharmaceuticals executives and independent directors trade stock every 8 days with the average trade being worth of $47,694,347. The most recent stock trade was executed by Marion Mc Court on 3 September 2024, trading 1,000 units of REGN stock currently worth $381,400.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron Pharmaceuticals executives and other stock owners filed with the SEC include: